First Time Loading...

Dynavax Technologies Corp
NASDAQ:DVAX

Watchlist Manager
Dynavax Technologies Corp Logo
Dynavax Technologies Corp
NASDAQ:DVAX
Watchlist
Price: 11.5 USD 0.97% Market Closed
Updated: May 29, 2024

Dynavax Technologies Corp
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Dynavax Technologies Corp
Gross Profit Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Dynavax Technologies Corp
NASDAQ:DVAX
Gross Profit
$189.7m
CAGR 3-Years
31%
CAGR 5-Years
106%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Gross Profit
$36.1B
CAGR 3-Years
3%
CAGR 5-Years
7%
CAGR 10-Years
10%
Gilead Sciences Inc
NASDAQ:GILD
Gross Profit
$20.8B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Gross Profit
$19.6B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Gross Profit
$8.8B
CAGR 3-Years
16%
CAGR 5-Years
26%
CAGR 10-Years
26%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Gross Profit
$11.3B
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
18%

See Also

What is Dynavax Technologies Corp's Gross Profit?
Gross Profit
189.7m USD

Based on the financial report for Mar 31, 2024, Dynavax Technologies Corp's Gross Profit amounts to 189.7m USD.

What is Dynavax Technologies Corp's Gross Profit growth rate?
Gross Profit CAGR 5Y
106%

Over the last year, the Gross Profit growth was -55%. The average annual Gross Profit growth rates for Dynavax Technologies Corp have been 31% over the past three years , 106% over the past five years .